Literature DB >> 645741

Serious infections caused by Streptococcus milleri.

H W Murray, K C Gross, H Masur, R B Roberts.   

Abstract

Viridans streptococci continue to be the most common etiologic agents in bacterial endocarditis. The spectrum of diseases other than endocarditis caused by these organisms, however, has received sparse attention. Moreover, little clinical information is available concerning the individual viridans streptococcal species. During the 16 months of this study, one species of viridans streptococci, Streptococcus milleri, caused a surprising number of clinically significant suppurative infections. Clinical syndromes included the following: abscesses, 10 cases; peritonitis, four cases; endocarditis, three cases; cholangitis, empyema and cellulitis, one case each. A gastrointestinal source was apparent in eight of these 20 cases. Review of 58 cases of viridans streptococcal endocarditis demonstrated that although Strep. milleri was an infrequent cause of endocarditis, this species was associated with an unusual frequency of suppurative complications. Our experience suggests that Strep. milleri may be more commonly associated with serious suppurative infections than other viridans streptococci and that species identification may be a clinically useful procedure.

Entities:  

Mesh:

Year:  1978        PMID: 645741     DOI: 10.1016/0002-9343(78)90514-4

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  41 in total

Review 1.  Streptococcus milleri group: renewed interest in an elusive pathogen.

Authors:  S C Piscitelli; J Shwed; P Schreckenberger; L H Danziger
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

2.  Acute vertebral osteomyelitis complicating Streptococcus sanguis endocarditis.

Authors:  C Demers; M Tremblay; Y Lacourcière
Journal:  Ann Rheum Dis       Date:  1988-04       Impact factor: 19.103

3.  Deep neck space abscesses of dental origin: the impact of Streptococcus group Milleri.

Authors:  Andrej Terzic; Paolo Scolozzi
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-11-17       Impact factor: 2.503

4.  Presumptive identification of "Streptococcus milleri" in 5 h.

Authors:  K L Ruoff; M J Ferraro
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

5.  Clinical significance of Streptococcus milleri.

Authors:  P Van der Auwera
Journal:  Eur J Clin Microbiol       Date:  1985-08       Impact factor: 3.267

6.  A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients.

Authors:  Christopher D Sibley; Michael D Parkins; Harvey R Rabin; Kangmin Duan; Jens C Norgaard; Michael G Surette
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-23       Impact factor: 11.205

7.  Prospective study of Streptococcus milleri hepatic abscess.

Authors:  J Corredoira; E Casariego; C Moreno; L Villanueva; J Varela; A Rodríguez; P Alonso; A Coira
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-08       Impact factor: 3.267

8.  Effect of penicillin on the adherence of Streptococcus sanguis in vitro and in the rabbit model of endocarditis.

Authors:  F D Lowy; D S Chang; E G Neuhaus; D S Horne; A Tomasz; N H Steigbigel
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

9.  Viridans streptococci septicemia in cancer patients: a clinical study.

Authors:  F Menichetti; A Del Favero; R Guerciolini; M Tonato; R F Frongillo; F Roila; S Pauluzzi
Journal:  Eur J Epidemiol       Date:  1987-09       Impact factor: 8.082

Review 10.  Streptococcus intermedius causing infective endocarditis and abscesses: a report of three cases and review of the literature.

Authors:  MaryAnn P Tran; Molly Caldwell-McMillan; Walid Khalife; Vincent B Young
Journal:  BMC Infect Dis       Date:  2008-11-10       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.